Zambon in the USA
Interview with Thibaud Eckenschwiller, Zambon USA CEO & President
Our BOSTON and PROMIS programs are of utmost importance in the US and globally since BOS and NCFB are severe respiratory diseases. The unmet need is very high and urgent as there are no approved treatments currently indicated for these patients.
Zambon USA Team
Together with their European colleagues, the American team has been laying the groundwork in preparation for two commercial launches, pending positive data and receiving the necessary regulatory approvals.